Sign in

Alto Neuroscience, Inc.

Sep-25 Sep-24 Sep-23 Sep-22 Sep-21
Total revenue 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.07 0.07 0.04 0.03 0.01
Operating income -0.07 -0.07 -0.04 -0.03 -0.01
Non-operating income (net) 0.00 0.01 0.00 0.00 0.00
Income before tax -0.06 -0.06 -0.04 -0.03 -0.01
Income tax expense -0.06
Net income -0.06 -0.06 -0.04 -0.03 -0.01
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.03 -0.12 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01
Operating income -0.03 0.12 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 -0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.03 -0.02 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Income tax expense 0.00 0.00 0.00
Net income -0.03 -0.02 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
5 days ago
Sep-25 Sep-24 Sep-23 Sep-22 Sep-21
Total cash and short-term investments + 0.18 0.17 0.08 0.05 0.03
Accounts receivable, net 0.00 0.00 0.00
Inventories 0.00
Other current assets 0.00 0.00 0.00 0.00 0.00
Total current assets 0.18 0.17 0.09 0.05 0.03
Total non-current assets + 0.01 0.01 0.00 0.00 0.00
Total assets 0.18 0.18 0.09 0.05 0.03
Total current liabilities + 0.01 0.01 0.01 0.01 0.00
Total non-current liabilities + 0.02 0.02 0.15 0.08 0.04
Total liabilities 0.03 0.03 0.16 0.09 0.04
Total stockholders' equity + 0.15 0.15 -0.07 -0.04 -0.01
Common shares outstanding 29 25 27 26 26
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22
Total cash and short-term investments + 0.26 0.18 0.14 0.15 0.16 0.17 0.18 0.19 0.21 0.08 0.05 0.00 0.05 0.05
Accounts receivable, net 0.00 0.00 0.00
Inventories 0.00
Other current assets 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.27 0.18 0.14 0.15 0.16 0.17 0.18 0.20 0.21 0.09 0.05 0.05 0.05
Total non-current assets + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 -0.05 0.00
Total assets 0.28 0.18 0.15 0.16 0.17 0.18 0.19 0.20 0.21 0.09 0.05 0.05
Total current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Total non-current liabilities + 0.02 0.02 0.03 0.03 0.03 0.02 0.01 0.01 0.01 0.15 0.11 0.08
Total liabilities 0.03 0.03 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.16 0.11 0.09
Total stockholders' equity + 0.24 0.15 0.11 0.12 0.14 0.15 0.17 0.18 0.19 -0.07 -0.06 0.04 -0.04
Common shares outstanding 33 32 27 27 27 27 27 27 27 27 27 27 27 26
5 days ago
Sep-25 Sep-24 Sep-23 Sep-22 Sep-21
Operating cash flow + -0.05 -0.05 -0.03 -0.02 -0.01
Cash flow from investing + 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.06 0.14 0.07 0.04 0.03
Change in cash 0.01 0.09 0.03 0.02 0.02
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22
Operating cash flow + -0.03 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Cash flow from investing + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.11 0.05 0.00 0.00 0.01 0.00 0.00 0.00 0.13 0.04 0.00 0.00 0.03 0.02
Change in cash 0.09 0.04 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.12 0.03 -0.01 -0.01 0.02 0.01
5 days ago

Alto Neuroscience, Inc. (ANRO) - Income Before Tax

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Depreciation And Amortization

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Interest Expense

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Interest Income

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Net Interest Income

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Operating Expenses

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Research And Development

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Selling General And Administrative

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Operating Income

1Y 2Y 5Y Max
10 days ago

Alto Neuroscience, Inc. (ANRO) - Costof Goods And Services Sold

1Y 2Y 5Y Max
10 days ago